Sunshine Biopharma, Inc. (SBFM) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 5.11M |
| Enterprise Value | -3.2M |
| P/E Ratio | -0.02 |
| PEG Ratio | -0 |
| Price/Sales Ratio | 0.01 |
| Price/Book Ratio | 0.01 |
| Enterprise/Revenue | -0.36 |
| Enterprise/EBITDA | 2.42 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | June 30, 2026 |
Profitability
| Profit Margin | -0.17 |
| Operating Margin | -0.15 |
AD
Management Effectiveness
| Return On Assets | -0.17 |
| Return On Equity | -0.24 |
Income Statement
| Revenue | 36.31M |
| Revenue/Share | 25.89 |
| Gross Profit | 11.92M |
| EBITDA | -5.62M |
| Net Income | -5.98M |
| Diluted EPS | -14.4 |
Balance Sheet
| Total Cash | 13.75M |
| Total Cash/Share | 10.07 |
| Total Debt | 678,338 |
| Total Debt/Equity | 0.02 |
| Current Ratio | 5.46 |
| Book Value Per Share | 20.17 |
Price History
| 52-Week Change | -99.09 |
| 52-Week High | 23.2 |
| 52-Week Low | 0.16 |
| Moving Average 50 Days | 0.85 |
| Moving Average 200 Days | 5.91 |
Statistics
| Average Volume | 5.57M |
| Shares Outstanding | 2.12M |
| % Held by Institutions | 0 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
| Last Split Date | June 01, 2026 |
AD
